Application of Tandem Mass Spectrometry in the Screening and Diagnosis of Mucopolysaccharidoses

Overview

Journal Orphanet J Rare Dis

Publisher Biomed Central

Specialty General Medicine

Date 2024 Apr 29

PMID 38685110

Authors

Jing-Wen Li

Shao-Jia Mao

Yun-Qi Chao

Chen-Xi Hu

Yan-Jie Qian

Yang-Li Dai

Ke Huang

Zheng Shen

Chao-Chun Zou

Affiliations

Soon will be listed here.

Abstract

Mucopolysaccharidoses (MPSs) are caused by a deficiency in the enzymes needed to degrade glycosaminoglycans (GAGs) in the lysosome. The storage of GAGs leads to the involvement of several systems and even to the death of the patient. In recent years, an increasing number of therapies have increased the treatment options available to patients. Early treatment is beneficial in improving the prognosis, but children with MPSs are often delayed in their diagnosis. Therefore, there is an urgent need to develop a method for early screening and diagnosis of the disease. Tandem mass spectrometry (MS/MS) is an analytical method that can detect multiple substrates or enzymes simultaneously. GAGs are reliable markers of MPSs. MS/MS can be used to screen children at an early stage of the disease, to improve prognosis by treating them before symptoms appear, to evaluate the effectiveness of treatment, and for metabolomic analysis or to find suitable biomarkers. In the future, MS/MS could be used to further identify suitable biomarkers for MPSs for early diagnosis and to detect efficacy.

References

Lin H, Lo Y, Wang T, Huang S, Tu R, Chen T . Normalization of glycosaminoglycan-derived disaccharides detected by tandem mass spectrometry assay for the diagnosis of mucopolysaccharidosis. Sci Rep. 2019; 9(1):10755. PMC: 6656773. DOI: 10.1038/s41598-019-46829-x. View

Courtney E, Pickens C, Cuthbert C, Petritis K . Multiplexing Iduronate-2-Sulphatase (MPS-II) into a 7-Plex Lysosomal Storage Disorder MS/MS Assay Using Cold-Induced Phase Separation. Int J Neonatal Screen. 2023; 9(2). PMC: 10298912. DOI: 10.3390/ijns9020032. View

Saville J, McDermott B, Fletcher J, Fuller M . Disease and subtype specific signatures enable precise diagnosis of the mucopolysaccharidoses. Genet Med. 2018; 21(3):753-757. DOI: 10.1038/s41436-018-0136-z. View

Khaliq T, Sadilek M, Scott C, Turecek F, Gelb M . Tandem mass spectrometry for the direct assay of lysosomal enzymes in dried blood spots: application to screening newborns for mucopolysaccharidosis IVA. Clin Chem. 2010; 57(1):128-31. PMC: 3442110. DOI: 10.1373/clinchem.2010.149880. View

Tomatsu S, Shimada T, Mason R, Montano A, Kelly J, LaMarr W . Establishment of glycosaminoglycan assays for mucopolysaccharidoses. Metabolites. 2014; 4(3):655-79. PMC: 4192686. DOI: 10.3390/metabo4030655. View

Chuang C, Lin H, Wang T, Huang Y, Chan M, Liao H . Status of newborn screening and follow up investigations for Mucopolysaccharidoses I and II in Taiwan. Orphanet J Rare Dis. 2018; 13(1):84. PMC: 5970538. DOI: 10.1186/s13023-018-0816-4. View

Lin H, Lee C, Lo Y, Tu R, Chang Y, Chang C . An At-Risk Population Screening Program for Mucopolysaccharidoses by Measuring Urinary Glycosaminoglycans in Taiwan. Diagnostics (Basel). 2019; 9(4). PMC: 6963841. DOI: 10.3390/diagnostics9040140. View

Bodamer O, Giugliani R, Wood T . The laboratory diagnosis of mucopolysaccharidosis III (Sanfilippo syndrome): A changing landscape. Mol Genet Metab. 2014; 113(1-2):34-41. DOI: 10.1016/j.ymgme.2014.07.013. View

He Q, Trim P, Lau A, King B, Hopwood J, Hemsley K . Synthetic Disaccharide Standards Enable Quantitative Analysis of Stored Heparan Sulfate in MPS IIIA Murine Brain Regions. ACS Chem Neurosci. 2019; 10(8):3847-3858. DOI: 10.1021/acschemneuro.9b00328. View

10.

Tomatsu S, Fujii T, Fukushi M, Oguma T, Shimada T, Maeda M . Newborn screening and diagnosis of mucopolysaccharidoses. Mol Genet Metab. 2013; 110(1-2):42-53. PMC: 4047214. DOI: 10.1016/j.ymgme.2013.06.007. View

11.

Wang D, Eadala B, Sadilek M, Chamoles N, Turecek F, Scott C . Tandem mass spectrometric analysis of dried blood spots for screening of mucopolysaccharidosis I in newborns. Clin Chem. 2005; 51(5):898-900. DOI: 10.1373/clinchem.2004.047167. View

12.

Taylor J, Clinard K, Powell C, Rehder C, Young S, Bali D . The North Carolina Experience with Mucopolysaccharidosis Type I Newborn Screening. J Pediatr. 2019; 211:193-200.e2. DOI: 10.1016/j.jpeds.2019.04.027. View

13.

DAvanzo F, Rigon L, Zanetti A, Tomanin R . Mucopolysaccharidosis Type II: One Hundred Years of Research, Diagnosis, and Treatment. Int J Mol Sci. 2020; 21(4). PMC: 7072947. DOI: 10.3390/ijms21041258. View

14.

Fachel F, Francio L, Poletto E, Schuh R, Teixeira H, Giugliani R . Gene editing strategies to treat lysosomal disorders: The example of mucopolysaccharidoses. Adv Drug Deliv Rev. 2022; 191:114616. DOI: 10.1016/j.addr.2022.114616. View

15.

Heon-Roberts R, Nguyen A, Pshezhetsky A . Molecular Bases of Neurodegeneration and Cognitive Decline, the Major Burden of Sanfilippo Disease. J Clin Med. 2020; 9(2). PMC: 7074161. DOI: 10.3390/jcm9020344. View

16.

Zhou J, Lin J, Leung W, Wang L . A basic understanding of mucopolysaccharidosis: Incidence, clinical features, diagnosis, and management. Intractable Rare Dis Res. 2020; 9(1):1-9. PMC: 7062595. DOI: 10.5582/irdr.2020.01011. View

17.

Beneto N, Vilageliu L, Grinberg D, Canals I . Sanfilippo Syndrome: Molecular Basis, Disease Models and Therapeutic Approaches. Int J Mol Sci. 2020; 21(21). PMC: 7659972. DOI: 10.3390/ijms21217819. View

18.

Zhang H, Dickson P, Stiles A, Chen A, Le S, McCaw P . Comparison of dermatan sulfate and heparan sulfate concentrations in serum, cerebrospinal fluid and urine in patients with mucopolysaccharidosis type I receiving intravenous and intrathecal enzyme replacement therapy. Clin Chim Acta. 2020; 508:179-184. DOI: 10.1016/j.cca.2020.05.035. View

19.

Kumar A, Masi S, Ghomashchi F, Chennamaneni N, Ito M, Scott C . Tandem Mass Spectrometry Has a Larger Analytical Range than Fluorescence Assays of Lysosomal Enzymes: Application to Newborn Screening and Diagnosis of Mucopolysaccharidoses Types II, IVA, and VI. Clin Chem. 2015; 61(11):1363-71. PMC: 4737431. DOI: 10.1373/clinchem.2015.242560. View

20.

Chuang C, Tu Y, Lee C, Lo Y, Chang Y, Liu M . Updated Confirmatory Diagnosis for Mucopolysaccharidoses in Taiwanese Infants and the Application of Gene Variants. Int J Mol Sci. 2022; 23(17). PMC: 9456254. DOI: 10.3390/ijms23179979. View